Drug Prices
Coastal Meds LLC, which compounds drugs as an outsourcing facility, has voluntarily recalled all of its products marketed as sterile due to visible particles in some of the drug vials for injection.
The price of the 20 most prescribed brand-name drugs in the Medicare Part D program increased an average 12% per year between 2012 and 2017, about 10 times more than the average annual rate of inflation.
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions Re: Perspectives on the 340B Drug Pricing Program
The Campaign for Sustainable Rx Pricing released a digital and television ad urging Congress to pass the Creating and Restoring Equal Access to Equivalent Samples Act to lower drug prices.
Also in this week’s roundup: Intermountain Healthcare’s efforts to extend medical services outside of traditional hospital walls; and a new survey showing more patients wanting access to digital health care.
WASHINGTON, DC (March 1, 2018) – Hospitals of all kinds provide a full range of benefits to their communities. In a new analysis released today, the American Hospital Associati
The U.S. health care system is facing a prescription drug spending crisis fueled by staggering increases in recent years in the price of drugs.
National health expenditures are projected to grow an average 5.5% annually during 2017-2026, outpacing average projected growth in gross domestic product by 1 percentage point, the Centers for Medicare & Medicaid Services’ Office of the Actuary reported yesterday.
The House Ways and Means Committee today held a hearing on the Department of Health and Human Services’ fiscal year 2019 budget request, at which HHS Secretary Alex Azar testified.
More than 40 organizations, including the AHA, today urged House and Senate leaders to swiftly pass the Creating and Restoring Equal Access to Equivalent Samples Act (S. 974/H.R. 2212).